We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$148B
AUM Growth
+$13.7B
Cap. Flow
+$2.5B
Cap. Flow %
1.69%
Top 10 Hldgs %
25.2%
Holding
4,104
New
267
Increased
1,933
Reduced
1,554
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 16.03%
2 Financials 9.11%
3 Healthcare 8.03%
4 Industrials 6.97%
5 Consumer Discretionary 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARKK icon
476
ARK Innovation ETF
ARKK
$6.38B
$40.5M 0.03%
809,182
-142,302
-15% -$6.94M
MPWR icon
477
Monolithic Power Systems
MPWR
$68.9B
$40.5M 0.03%
59,800
-12,819
-18% -$8.56M
CM icon
478
Canadian Imperial Bank of Commerce
CM
$109B
$40.4M 0.03%
796,416
-628
-0.1% -$29.7K
IDXX icon
479
Idexx Laboratories
IDXX
$46.2B
$40.1M 0.03%
74,334
+1,399
+2% +$765K
XYZ
480
Block Inc
XYZ
$47.5B
$39.8M 0.03%
470,618
+50,513
+12% +$3.65M
XBI icon
481
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$39.7M 0.03%
418,704
+103,077
+33% +$9.56M
FBND icon
482
Fidelity Total Bond ETF
FBND
$27.3B
$39.7M 0.03%
875,122
+65,477
+8% +$2.97M
PPL
483
PPL Corp
PPL
$26.5B
$39.6M 0.03%
1,439,791
+82,458
+6% +$2.19M
RJF icon
484
Raymond James Financial
RJF
$34.6B
$39.6M 0.03%
308,363
-2,948
-0.9% -$344K
EMN icon
485
Eastman Chemical
EMN
$8.55B
$39.3M 0.03%
392,577
-18,456
-4% -$1.62M
HCA icon
486
HCA Healthcare
HCA
$89.1B
$38.9M 0.03%
116,639
-24,051
-17% -$7.35M
EXPO icon
487
Exponent
EXPO
$3.25B
$38.7M 0.03%
467,984
+957
+0.2% +$79.2K
VONE icon
488
Vanguard Russell 1000 ETF
VONE
$8.65B
$38.7M 0.03%
162,362
-8,341
-5% -$1.89M
PRFZ icon
489
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.88B
$38.5M 0.03%
980,138
-27,328
-3% -$1.02M
CAH icon
490
Cardinal Health
CAH
$56.3B
$38.4M 0.03%
343,461
+54,129
+19% +$5.84M
TLH icon
491
iShares 10-20 Year Treasury Bond ETF
TLH
$10.8B
$38.3M 0.03%
364,236
-12,126
-3% -$1.27M
VLTO icon
492
Veralto
VLTO
$23.9B
$38.2M 0.03%
+431,115
New +$35.7M
IDA icon
493
Idacorp
IDA
$8.11B
$38.1M 0.03%
410,454
+47,639
+13% +$4.36M
LNG icon
494
Cheniere Energy
LNG
$54.8B
$38.1M 0.03%
236,144
-14,252
-6% -$2.29M
WTW icon
495
Willis Towers Watson
WTW
$31.8B
$37.9M 0.03%
137,835
-6,271
-4% -$1.65M
IWP icon
496
iShares Russell Mid-Cap Growth ETF
IWP
$20.8B
$37.7M 0.03%
330,649
-19,930
-6% -$2.16M
PULS icon
497
PGIM Ultra Short Bond ETF
PULS
$18.4B
$37.7M 0.03%
759,195
+180,871
+31% +$8.96M
DTE icon
498
DTE Energy
DTE
$28.6B
$37.4M 0.03%
333,766
+124,278
+59% +$13.4M
THO icon
499
Thor Industries
THO
$4.23B
$37.4M 0.03%
318,566
+18,484
+6% +$2.12M
VNQ icon
500
Vanguard Real Estate ETF
VNQ
$38.3B
$37.3M 0.03%
430,907
-5,336
-1% -$456K

Similar funds

Raymond James & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Raymond James & Associates held 4,104 positions worth $148B, up 10% from $134B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q1 2024 filing shows 267 new, 1,933 increased, 1,554 reduced and 192 closed positions. Its largest new stake was Veralto: 431,115 shares worth $38.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $233M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2024 buy was Veralto: 431,115 shares worth $38.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2024, an estimated $292M increase.
  • Raymond James & Associates's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $233M.
  • Raymond James & Associates fully exited Splunk Inc in Q1 2024, selling an estimated $14.6M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $148B portfolio in Q1 2024.
  • Raymond James & Associates opened 267 new positions and closed 192 in Q1 2024.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $148B.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.